About
MDVerse develops software, analytics, and AI/ML solutions to facilitate the delivery of advanced cell and gene therapies, supporting CDMOs, pharma, and academic institutions in the regenerative medicine and clinical supply chain.
Explore MDVerse's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.